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Metabolic perturbations that decrease or limit blood glucose—such as fasting or adhering to a ketogenic diet—reduce epileptic seizures
significantly. To date, the critical links between altered metabolism and decreased neuronal activity remain unknown. More generally,
metabolic changes accompanynumerousCNSdisorders, and the purinesATP and its coremolecule adenosine are poised to translate cell
energy into altered neuronal activity. Here we show that nonpathological changes in metabolism induce a purinergic autoregulation of
hippocampal CA3 pyramidal neuron excitability. During conditions of sufficient intracellular ATP, reducing extracellular glucose in-
duces pannexin-1 hemichannel-mediated ATP release directly from CA3 neurons. This extracellular ATP is dephosphorylated to aden-
osine, activates neuronal adenosineA1 receptors, and, unexpectedly, hyperpolarizes neuronalmembranepotential viaATP-sensitiveK

channels. Together, these data delineate an autocrine regulation of neuronal excitability via ATP and adenosine in a seizure-prone
subregion of the hippocampus and offer newmechanistic insight into the relationship between decreased glucose and increased seizure
threshold. By establishing neuronal ATP release via pannexin hemichannels, and hippocampal adenosine A1 receptors coupled to
ATP-sensitive K channels, we reveal detailed information regarding the relationship between metabolism and neuronal activity and
new strategies for adenosine-based therapies in the CNS.
Introduction
ATP and adenosine play dual roles in the nervous system. These
purines participate in both cell energy and extracellular signaling
and thus link metabolism and neuronal activity (Kato et al.,
2004). Furthermore, ATP and adenosine are key signals between
neurons and glia (Fellin et al., 2006), interact directly with other
neurotransmitter systems (Ferre´ et al., 2007; Sichardt andNieber,
2007), and are influenced dynamically by changes in ongoing
physiology (Dunwiddie and Masino, 2001; Dulla et al., 2005,
2009). A more comprehensive understanding of the physio-
logical or cellular mechanisms regulating ATP and adenosine
holds promise for a variety of acute and chronic neurological
disorders, particularly adenosine-augmenting therapies for
brain injury, epilepsy, and neurodegenerative diseases (Boison,
2006; Li et al., 2008). To date, however, adenosine receptor-based
strategies to stop seizures and enhance neuronal survival have
been hampered by unacceptable side effects (Dunwiddie, 1999;
Elzein and Zablocki, 2008).
In hippocampus and cerebral cortex, tonic extracellular aden-
osine inhibits neuronal activity presynaptically and postsynapti-
cally via the adenosine A1 receptor (A1R) subtype (Dunwiddie
and Masino, 2001). Recent evidence revealed gap junction
hemichannels located on astrocytes (Fellin et al., 2006) and ve-
sicular ATP release from astrocytes as sources of extracellular
ATP (Pascual et al., 2005), confirmed the extracellular dephos-
phorylation of astrocyte-derived ATP to adenosine (Pascual et
al., 2005), and demonstrated the significant influence of
astrocyte-derived adenosine on brain activity via A1Rs (Fellin et
al., 2006). Notably, hemichannels can reduce ischemic damage
(Schock et al., 2008) and precipitate preconditioning (Lin et al.,
2008), conditions in which A1Rs can play a critical inhibitory and
neuroprotective role (Heurteaux et al., 1995; Johansson et al.,
2001). Together, these findings underscore the signaling part-
nerships between neurons and glia, ATP and adenosine, and
metabolism and neuronal activity, and highlight the therapeu-
tic importanceof understandingof thedynamics of ongoingmetab-
olism, neuronal excitability, and the regulation of extracellular
ATP and adenosine.
Whereas altered metabolism is a hallmark of many neurolog-
ical conditions (Sas et al., 2007; Rezin et al., 2009), a cause-and-
effect relationship is often unknown. One clear exception is
observed during adherence to a high-fat low-carbohydrate (ke-
togenic) diet, a metabolic therapy recognized for decades to offer
significant anticonvulsant benefits, particularly in pediatric and
medically refractory epilepsy (Wilder, 1921; Neal et al., 2008).
Ketogenic metabolism is characterized by moderate hypoglyce-
mia, mitochondrial biogenesis and increased cell energy mole-
cules (DeVivo et al., 1978; Nakazawa et al., 1983; Bough et al.,
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2006), yet the critical neuronalmechanism(s) underlying the suc-
cess of dietary therapy remains enigmatic. To characterize and
quantify the relationship between cell energy and neuronal excit-
ability, wemanipulated intracellular and extracellular energy and
mimicked key aspects of ketogenicmetabolism during whole-cell
patch-clamp recordings in acute hippocampal slices. Here we
report that clinically relevant conditions of reduced extracellular
glucose with sufficient or increased intracellular ATP induce a
novel autocrine regulation of CA3 pyramidal neuron excitability.
We show that this effect is consequent to direct ATP release via
pannexin-1 hemichannels, extracellular adenosine acting at A1Rs,
and activation of ATP-sensitive K (KATP) channels.
Materials andMethods
Slice preparation.All experiments were performed in accordancewith the
Guide for the Care and Use of Laboratory Animals and approved by the
Trinity College animal use committee. Sprague Dawley rats or C57BL/6
mice [wild type or lacking A1Rs (Johansson et al., 2001)] aged 4–8 weeks
of either sex were anesthetized with isoflurane and decapitated (age
within this range and sex had no significant effect on the amplitude of
reduced extracellular glucose ([glucose]e)-induced outward current)
(supplemental Fig. 1, available at www.jneurosci.org as supplemental
material).
Standard slice preparation and recording conditions were used, simi-
lar to our previous publications (Masino et al., 2002; Kawamura et al.,
2004). Briefly, three to five coronal hippocampal slices of 300 m thick-
ness weremade in ice-cold artificial CSF (aCSF) containing the following
(in mM): 126 NaCl, 3 KCl, 1.5 MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 11 glu-
cose, 26 NaHCO3 (osmolarity 320 mOsm, pH 7.4, when saturated with
95% O2 plus 5% CO2) with a vibrating slice cutter (Series 1000, Vi-
bratome). The slices were incubated in aCSF saturated with 95%O2 plus
5%CO2 for 30–40min at 37°C, then kept at room temperature until the
recording. The slice was fixed in a recording chamber (0.4 ml volume,
RC-26, Warner Instruments) under nylon mesh attached to a U-shaped
platinum frame and submerged in and continuously perfused with aCSF
at a flow rate of 2 ml min1 at 3234°C.
Extracellular glucose was reduced but never removed completely (re-
duced from standard aCSF with 11 mM to either 3 or 7 mM). Standard
[glucose]e in aCSF is maintained at a higher concentration than in vivo
(in which it is closer to 3 mM; Shram et al., 1997); using extracellular
recordings we confirmed that switching to 3mM [glucose]e in slices is not
pathological (nomore than a 12.25% decrease in amplitude measured at
25 min; n 4, data not shown).
Reduced [glucose]e was achieved by replacing glucose with sucrose.
Only one change in [glucose]e or one manipulation of any kind (i.e.,
pharmacological characterization, ATP manipulation) was tested in
each slice. CA3 pyramidal cells or astrocytes were visually identified
with an infrared-differential interference contrast (IR-DIC) videomi-
croscope (Zeiss Axioskop2 FS plus, Carl Zeiss; CoolSnap HQ camera,
PhotoMetrics).
Whole-cell transmembrane current recordings. Patch electrodes (3–5
M) were fabricated from borosilicate glass capillaries of 1.5 mm outer
diameter with a programmable puller (P-97, Sutter Instruments) and
filledwith an intracellular solution containing the following (inmM): 117
K-gluconate, 3.0 KCl, 1.0 EGTA, 3.0 MgCl2, 10.0 HEPES (free acid), 1.0
CaCl2, 2.0 Mg
2-ATP, pH 7.3, with KOH. When changing [ATP],
Mg2-ATP was replaced by KCl and MgCl2. [ATP] in the pipette was
typically 2.0 mM but was also held at 0.5, 1.0, and 5.0 mM as described
in specific experiments below. Only one [ATP] was tested per neuron.
The 2.0 mM intracellular adenosine concentration solution was made
by adding 2.0 mM adenosine to the 0.5 mM ATP intracellular solution. A
cesium-based intracellular solution containing the following (in mM):
117 Cs-methanesulfonate, 3.0 CsCl, 1.0 EGTA, 3.0 MgCl2, 10.0 HEPES,
1.0 CaCl2, 2.0Mg
2-ATP was used to obtain the I–V curve shown below
(see Figure 7). To visually identify the astrocytes (supplemental Fig. 4,
available at www.jneurosci.org as supplemental material), Lucifer yellow
was included in the cesium-based intracellular solution (0.5 mg/ml) and
visualized by excitation with a 495 nm xenon lamp with a fluorescent
microscope (Zeiss Axioskop2 FS plus and LAMBDA DG-4, Sutter
Instruments).
After obtaining a cell-attached configuration (1–10 G seal resis-
tance), the whole-cell recording mode was established with a brief nega-
tive current and pressure pulses. Recording started at least 15 min after
the rupture of the patch membrane to allow stabilization of the intracel-
lular milieu. Neurons showing unstable or large (more than 50 pA)
holding currents were rejected, and holding current was required to be
stable for a minimum of 5 min to proceed. Series resistance (40 M)
and membrane capacitance were compensated and checked regularly.
Unless otherwise noted, during recording the membrane potential was
held at 70 mV corrected for liquid junction potential. To measure
input resistance, negative currents of 100 pA were applied for 1 s every
30 s (Fig. 1). For measuring the I–V curve of the outward currents, the
ramp voltage commands (50 mV to 150 mV at 100 mV/s; duration
time, 1 s) were applied before and during reduced [glucose]e application
(see Fig. 4A). Below (see Fig. 7), ramp voltage commands (60 to120
mV, 180 mV/s; duration time 1 s) were applied every 1 min due to the
very slight inward current. The transmembrane current and potential
were recorded with a MultiClamp 700A amplifier (Molecular Devices)
with the high-cutoff filter at 2 kHz. The membrane current was digitized
(16-channel A/D board, National Instruments) and analyzed on-line
using Igor Pro 5 with Igor NIDAQ Tools MX (WaveMetrics).
Drugs and their application. All chemicals and drugs were purchased
from Sigma. Pannexin-1 mimetic blocking peptide 10panx (WRQAAFVDSY,
with C-terminal amidation) was synthesized by Biomatik. As described
in our previous publications (Masino and Dunwiddie, 1999; Dulla et al.,
2005, 2009), all drugs were dissolved in aCSF at 100 times the desired
final concentration and applied via syringe pump (Model A-99, Razel
Figure 1. Reduced [glucose]e causes hyperpolarization in rat CA3 pyramidal neurons.A, The
membrane potential trace (top) and the time course of the changes in the input resistance
(bottom) in the CA3 pyramidal neuron recorded with standard (2 mM) ATP in the intracellular
solution. Negative currents of 100 pA were applied every 30 s to measure input resistance. The
[glucose]e was switched from 11 to 3mM at the horizontal bar (reduced glucose).B, C, Summa-
ries of the effect of low-glucose extracellular solution on the membrane potentials (B) and the
input resistances (C). *p 0.05; **p 0.01; n 5.
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Scientific Instruments) to reach the final bath concentration. In all fig-
ures, the point indicated as the onset of drug application is the calculated
time when the solution first begins to mix into the volume of the slice
chamber. For pretreatments, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX),
carbenoxolone (CBX), octanol, BaCl2, or tolbutamide was perfused at
least for 10 min before testing the effects of reduced [glucose]e. After
application of any antagonist or blocker, no additional neurons were
recorded from that slice. Because there was never more than one manip-
ulation per slice, nomore than one neuron from any slice was included in
the final dataset.
Data and statistical analysis.The recordedmembrane potential or cur-
rent was analyzed off-line with Igor Pro 5. The application of reduced
[glucose]e and drugs is indicated at the time point these solutions began
to enter the slice chamber. The amplitude of the outward current was
measured as the difference between baseline before changing [glucose]e
and the peak current (in reduced [glucose]e) and as the difference be-
tween the baseline current and the current remaining after reversal by an
antagonist. When no significant change in current was detected after the
pretreatment with antagonists, the amplitude of the outward current was
measured at 12 min after reduced [glucose]e. This time point was stan-
dardized and determined by the average time to peak current with 3 mM
[glucose]e applied during 2 mM [ATP]i (739.39  69.68 s; n  9). The
mean spontaneous postsynaptic current (PSC) frequency was quantified
during a 1 min baseline period, during reduced [glucose]e(either at the
peak of the outward current or 12 min after reduced [glucose]e in pre-
treatment experiments when no change in current was observed), and
after blocker application to compare spontaneous PSC frequencies. The
PSCs were counted with using an Igor Pro procedure. All detected events
were monitored and checked visually to ensure that all detected events
had typical PSC waveforms. All data are expressed as mean SE (SEM).
Amplitudes of reduced [glucose]e-induced outward currents were com-
pared with one-way ANOVA; spontaneous PSC frequencies were com-
pared with paired t test. p 0.05 was considered significant.
Results
Reduced glucose and A1R-mediated inhibition
During whole-cell recording of visualized CA3 pyramidal neu-
rons in rat hippocampal slices we manipulated intracellular ATP
([ATP]i) and/or [glucose]e. CA3 is a region with recurrent exci-
tatory collaterals, used often for in vitro models of epilepsy and
central to some types of seizure disorders. While most in vitro
studies of hypoglycemia use a nominally glucose-free solution—
often combined with hypoxia or anoxia to mimic conditions
during an ischemic stroke—we used a nonpathological and
physiologically relevant condition of reduced [glucose]e.
Upon reducing [glucose]e to 3 mM during current-clamp re-
cordings we observed a significant and reversible hyperpolariza-
tion and concomitant decrease in input resistance (Fig. 1). We
tested the influence of intracellular ATP on this low-glucose-
induced hyperpolarization by loading whole-cell patch pipettes
with a range of [ATP]i (0.5–5.0 mM; standard solution contains
2.0 mM). During voltage-clamp recordings (holding potential
70 mV), we found that [ATP]i bidirectionally determines the
effects of reduced [glucose]e (Fig. 2A,B). [ATP]i concentrations
of 1.0 mM all resulted in a significant outward current, while
when [ATP]i was reduced to 0.5 mM, reduced [glucose]e caused a
large but transient inward current (Fig. 2A,B). A linear relation-
ship held for [ATP]i between 0.5 and 2.0 mM but not for 5.0 mM
[ATP]i; at this concentration the amplitude of the outward cur-
rent was reduced (Fig. 2A,B). During normal [ATP]i (2.0 mM)
the effects of reducing [glucose]e are dose-dependent, with an
inverse relationship between [glucose]e and the amplitude of the
outward current (Fig. 2C). In addition, spontaneous PSC fre-
quency was inhibited in a dose-dependent manner by both
[ATP]i (Fig. 2D; supplemental Fig. 2A, available at www.
jneurosci.org as supplemental material) and [glucose]e (supple-
mental Fig. 2B, available at www.jneurosci.org as supplemental
material). Unlike the amplitude of the outward current, the linear
relationship between [ATP]i and the inhibition of PSC frequency
persisted with 5.0 mM [ATP]i, suggesting insensitivity to [ATP]i
and thus mediation by different mechanisms. EPSCs but not
IPSCs are sensitive to adenosine in CA3 pyramidal neurons
(Thompson et al., 1992; Kawamura et al., 2004). Thus, presynap-
tic inhibition (measured as decreased PSC frequency) and
Figure 2. The effect of different concentrations of intracellular ATP or extracellular glucose
on the reduced [glucose]e-induced outward current in CA3 pyramidal neurons. A, The mem-
brane current traces of four different intracellular ATP concentrations ([ATP]i 5, 2, 1, and 0.5
mM) with reducing [glucose]e from 11 to 3 mM (reduced glucose). The holding potential was
70mV. B1, B2, Summaries of the significant effect of intracellular ATP concentration on the
peak current amplitude (B1) and the amplitude 12 min after changing the glucose concentra-
tion (B2) in reduced glucose-induced outward currents ([ATP]i 0.5 mM, n 4; [ATP]i 1
mM, n 5; [ATP]i 2 mM, n 9; [ATP]i 5 mM, n 4). C, Summary of the significant
dose-dependency of the effects of reduced [glucose]e with [ATP]i 2 mM (3 mM [glucose]e,
n 9; 7 mM [glucose]e, n 5). D, PSC frequency was decreased significantly by reduced
[glucose]e with a dose-dependent relationship to [ATP]i. *p 0.05; **p 0.01.
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postsynaptic hyperpolarization (measured as increased out-
ward current amplitude) are both altered significantly and con-
sistently by small changes in [ATP]i and [glucose]e.
Hypoglycemia is known to increase extracellular adenosine
(Fowler, 1993), and presynaptic and postsynaptic A1Rs cause
decreased spontaneous excitatory PSC frequency and hyperpo-
larization, respectively, in CA3 pyramidal neurons (Kawamura et
al., 2004). We determined the role of A1Rs in this reduced
[glucose]e-induced outward current by applying a selective A1R
antagonist, DPCPX (1.0M). As expected, DPCPX itself caused a
small inward current and increase of PSC frequency, due to
blocking tonic activation of presynaptic and postsynaptic A1Rs
(Fig. 3A; supplemental Fig. 3A, available at www.jneurosci.org as
supplemental material). DPCPX reversed or prevented com-
pletely the outward current observed during reduced [glucose]e
(Fig. 3A), and also blocked the decrease in PSC frequency (supple-
mental Fig. 3A, available at www.jneurosci.org as supplementalma-
terial). Genetic knock-out confirmed these
pharmacological results: reduced [glucose]e
induced a significant outward current in
CA3 pyramidal neurons recorded from
wild-type mouse slices but had no effect
on those recorded from A1R knock-out
mouse slices (Fig. 3B). Thus, during
conditions of sufficient or high [ATP]i, re-
duced [glucose]e caused a significant A1R-
mediated regulation of neuronal activity.
Note that current traces aremore stable in
the presence of an antagonist or in theA1R
knock-out mouse slices, perhaps due to
eliminating the dynamics of the autocrine
mechanismwith a pharmacological or ge-
netic block.
The reversal potential and shape of the
current–voltage ( I–V) curve of the out-
ward current-induced by reduced [glu-
cose]e indicated that inwardly rectifying
K channels were opened (Fig. 4A). Ini-
tially, to test the coupling of A1Rs to K

channels in CA3, we applied barium chlo-
ride (BaCl2), a nonselective K
 channel
antagonist, either before or after the ap-
plication of reduced [glucose]e while re-
cording with a patch pipette loaded with
2.0 mM [ATP]i. BaCl2 (1.0 mM) itself
caused a small inward current, likely
due to tonic activation of A1Rs and their
coupling to postsynaptic K channels
(Fig. 4B). BaCl2 reversed or prevented
the effects of reduced [glucose]e (Fig.
4B), identifying K channels as the
source of outward current induced by
reduced [glucose]e.
A1Rs couple to KATP channels in CA3
pyramidal neurons
Postsynaptic activation of A1Rs is associ-
ated traditionally with G-protein-coupled
inwardly rectifying K (GIRK) channels
in CA1 pyramidal neurons, but detailed
studies have not been published in CA3
pyramidal neurons, and BaCl2 nonselec-
tively blocks both GIRK and KATP chan-
nels (Guatteo et al., 1998). The amplitude of outward current
induced with reduced [glucose]e was attenuated in 5.0 mM
[ATP]i (Fig. 2A,B), indicating that high [ATP]i may be inhib-
iting the effects of reduced [glucose]e. In contrast to the
postsynaptic effect in the CA3 neuron, the inhibition of PSC
frequency was related linearly to [ATP]i (Fig. 2D). Brain KATP
channels can link to A1Rs (Andoh et al., 2006), and these K

channels are expressed functionally in CA3 pyramidal neurons
(Griesemer et al., 2002).
To determine whether KATP channels were involved in the
outward current induced with reduced [glucose]e we applied tol-
butamide (500 M), a selective KATP channel blocker. Tolbut-
amide alone had no effect on the holding potential (Fig. 5A),
suggesting that tonic A1R activation in CA3 pyramidal neu-
rons is not coupled specifically to KATP channels. However,
tolbutamide significantly reversed or prevented the outward
current caused by reduced [glucose]e (Fig. 5A). The decrease in
Figure 3. Reduced [glucose]e-induced outward current is mediated by activation of A1Rs. A, DPCPX (1M) reversed signifi-
cantly (top)orprevented (bottom) completely the reduced [glucose]e-inducedoutward current inCA3pyramidal neurons recorded
from Sprague Dawley rat hippocampal slices. Average data shown in right panel for reversal (top right; n 5) and prevention
(bottom right; n 4). B, Reduced [glucose]e caused a significant DPCPX-sensitive outward current in CA3 neurons recorded from
wild-type (WT) mouse (top left) but had no effect on CA3 neurons recorded from the A1R receptor knock-out (A1R-KO) mouse
(bottom left). Average data shown in right panel for WT mice (n 6) and A1R-KO mice (n 8). NS, Not significantly different;
**p 0.01.
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PSC frequency with reduced [glucose]e
was not inhibited by tolbutamide (Fig.
5B) or BaCl2 (supplemental Fig. 3B, avail-
able at www.jneurosci.org as supplemen-
talmaterial), indicating that the decreased
PSC frequency is due to a distinct non-K
channel presynaptic mechanism. Together,
the results shown in Figures 3–5 demon-
strate that the reduced [glucose]e-induced
outward current ismediated by the opening
of postsynaptic KATP channels linked to the
activation of A1Rs.
Direct ATP release from
pannexin-1 hemichannels
Increased extracellular adenosine activat-
ing A1Rs could be consequent to the de-
phosphorylation of extracellular ATP or
direct adenosine release via nucleoside
transporters. Previous research indicates
that the direction of adenosine transport
is predominantly inward and serves to re-
move adenosine from the extracellular
space (Dunwiddie and Diao, 1994). In
contrast, ATP has been shown to efflux
directly from astrocytes, either via hemi-
channels or vesicular release (Fellin et
al., 2006). To determine physiologically
whether the increase in A1R activity was
caused by direct efflux of adenosine or of
ATP, we loaded cells with a combination
of 2.0 mM adenosine and 0.5 mM ATP. As
we determined previously, in reduced
[glucose]e 0.5 mM [ATP]i causes an in-
ward current and 2.0mM [ATP]i causes an
outward current (Fig. 2A,B). Thus this
test combination provided some cell en-
ergy (0.5 mM [ATP]i) and an adenosine
concentration equivalent to the ATP con-
centration shown to produce the biggest
outward current during reduced [glu-
cose]e (2 mM [ATP]i) (Fig. 2A,B). Upon
intracellular loading with 2.0 mM adeno-
sine and 0.5 mM ATP, reduced [glucose]e
caused small transient outward current,
significantly lower in amplitude that ob-
served with 2.0 mM [ATP]i (Fig. 6A). No
significant current was observed after 15
min, unlike with 2.0mM [ATP]i (Fig. 6A),
indicating that the larger and sustained
outward current observed during reduced
[glucose]e with 2.0 mM [ATP]i was not
caused by the direct release of adenosine.
A similar pattern was found with PSCs:
upon intracellular loading with 2.0 mM
adenosine and 0.5 mM ATP, PSC fre-
quency was not different from that found
with 0.5mM [ATP]i alone (0.50 0.11Hz
vs 0.48 0.10 Hz, n 7, nonsignificant).
This small and transient effect of 2.0 mM
intracellular adenosine is in contrast to
the larger and sustained inhibitory effect
of reduced [glucose]e with 2.0 mM [ATP]i
Figure 4. Reduced [glucose]e opens K
 channels in rat CA3 pyramidal neurons. A, I–V relationship of the outward current
generated with reduced [glucose]e. The ramp voltage command (50mV to150mV at 100mV/s) was applied before (1) and
during (2) reduced [glucose]e application. The reversal potential (Erev) of theoutward currentwas92.751.67mV(n4). The
I–V relationship showed inward rectification and the average Erev was similar to the equilibrium potential for K
:92.89 mV.
B, BaCl2 (1mM) reversed (left traceand rightpanel;n5)orprevented (pretreatment, rightpanel;n4) completely theoutward
current caused with reduced glucose.
Figure 5. Postsynaptic KATP channels are opened by reduced [glucose]e. A, Tolbutamide (500 M) reversed (left trace
and right panel; n  5) or prevented (pretreatment, right panel; n  4) significantly the outward current caused by
reduced glucose. B, Tolbutamide did not prevent (right) or reverse (left traces and middle) the decrease in PSC frequency
with reduced glucose. Left traces “1” through “3” are time-extended traces taken at the indicated points in A. NS, Not
significantly different; *p 0.05; **p 0.01.
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(Fig. 2D), indicating that reduction of PSC frequency was not
caused by the direct release of adenosine.
To determine pharmacologically whether CA3 pyramidal
neurons were releasing ATP directly, we applied both selective
and nonselective gap junction hemichannel antagonists. We
could both reverse and prevent the outward current caused by
reduced [glucose]e significantly with either CBX (10 or 100 M)
(Fig. 6B) or octanol (1.0 mM) (Fig. 6C). The decrease in sponta-
neous PSC frequency was also inhibited significantly by CBX
(supplemental Fig. 3C, available at www.jneurosci.org as supple-
mental material) or octanol (supplemental Fig. 3D, available at
www.jneurosci.org as supplemental material), suggesting that
presynaptic and postsynaptic A1R activation is subsequent to
ATP released by gap junction hemichannels during reduced [glu-
cose]e. Similar results were obtained with a low concentration of
CBX (10 M) known to block pannexin but not connexin
hemichannels (Romanov et al., 2007) (Fig. 6B). To confirm
pannexin hemichannel opening in CA3 neurons, we tested a
specific inhibitor of pannexin-1 hemichannels (Pelegrin and
Surprenant, 2006; Thompson et al., 2008). The peptide 10panx
(100M) significantly reduced or prevented the outward current
(Fig. 6D) and decrease in spontaneous PSC frequency with re-
duced [glucose]e (supplemental Fig. 3E, available at www.
jneurosci.org as supplemental material). This pharmacology
indicates direct ATP release through pannexin-1 hemichannels,
during sufficient or high [ATP]i and reduced [glucose]e.
To determine physiologically the identity of the channel
opened, we did an I–V analysis of the isolated current recorded
during reduced [glucose]e. Opening pannexin hemichannels
causes current flow across cell membranes, yet we did not detect
any change in membrane current even while preventing the K
conductance in the presence of DPCPX, BaCl2 or tolbutamide at
Figure 6. Autocrine regulation due to ATP release through pannexin-1 hemichannels during reduced [glucose]e. A, With 2 mM intracellular adenosine ([Ado]i) and 0.5 mM [ATP]i, reduced
[glucose]e caused a small, transient outward current. The peak amplitude with 2 mM [Ado]i was significantly smaller than that with 2 mM [ATP]i (left), and unlike with 2 mM [ATP]i, no significant
current was observed after 15min (2mM [ATP]i, n 9; 2mM [Ado]i and 0.5mM [ATP]i, n 7; right).B, CBX (10 or 100M) reversed (top trace and lower left; n 5 per group) or prevented (lower
right; n 4 per group) significantly the outward current caused with reduced glucose. C, Octanol (1 mM) reversed (top trace and lower left; n 5) or prevented (lower right; n 4) significantly
the outward current caused with reduced glucose. D, 10panx (100M) reversed (top trace and lower left; n 5) or prevented (lower right; n 4) significantly the outward current caused with
reduced glucose. NS, Not significantly different; **p 0.01.
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a holding potential of 70 mV (Figs. 3A, 4B, and 5A, respec-
tively). At a 90 mV holding potential, however, reduced [glu-
cose]e caused a slight inward current in CA3 pyramidal neurons
in the presence of tolbutamide (peak inward current 5.49 3.10
pA; p  0.13). We checked the I–V curve of this slight inward
current with cesium-based intracellular solution in the presence
of extracellular tolbutamide.Under these conditionswe recorded
a nonlinear I–V relationship with a reversal potential near 35
mV in CA3 pyramidal neurons (Fig. 7A) but not in astrocytes in
stratum radiatum (Fig. 7B). This nonlinear I–V relationship and
reversal potential are most similar to those recorded from
pannexin hemichannels (Romanov et al., 2007). The I–V curve
with reduced [glucose]e was suppressed significantly by CBX or
by 10panx (Fig. 7A), indicating that this nonlinear I–V curve
stems from pannexin-1 hemichannel opening in CA3 pyramidal
neurons.
Together, the data presented herein elucidate a novel and
comprehensive autocrine regulation of CA3 pyramidal neuron
excitability. Under physiologically relevant conditions of reduced
[glucose]e and sufficient [ATP]i, CA3 pyramidal neurons release
ATP directly from pannexin-1 hemichannels, extracellular ATP
is dephosphorylated to adenosine which acts at A1Rs, and A1Rs
couple to KATP channels (Fig. 8).
Discussion
To date, the relative roles of [ATP]i versus [glucose]e in the dy-
namic regulation of extracellular adenosine have not been well
established, yet are relevant to both normal physiology as well as
clinical conditions such as stroke and metabolic maintenance on
ketogenic diet therapy. Both of these clinical situations result in
reduced [glucose]e, but only one (stroke) appears to be asso-
ciated with a significant loss of [ATP]i. Here, we demonstrate
a novel autocrine regulation of CA3 pyramidal neuron activity
upon a metabolic shift characteristic of ketogenic metabolism:
reduced [glucose]e coupled with sufficient or high [ATP]i
causes a significant hyperpolarization and decreased neuronal
excitability—consistent with the anticonvulsant and neuro-
protective effects of the ketogenic diet (and fasting (Davis et
al., 2008)). Conversely, low [ATP]i and reduced [glucose]e
caused pyramidal neuron depolarization—consistent with
anoxic depolarization observed in models of ischemia and
mild stroke (Yamamoto et al., 1997).
The effects of reduced [glucose]e during sufficient/high
[ATP]i are due to increased extracellular adenosine acting at
A1Rs. The outward current induced by reduced [glucose]e was
prevented or reversed completely by a selective A1R antagonist.
None of the electrophysiological consequences of high [ATP]i
and reduced [glucose]e were observed in A1R knock-out mouse
tissue, validating A1Rs as a critical link between changes in me-
tabolism and altered neuronal excitability. Because the outward
current mobilized by reduced [glucose]e was not reproduced by
intracellular loading with a concentration of adenosine equal to
the most effective concentration of ATP, it was initial evidence
that the releasedmolecule is ATP, which would be dephosphory-
lated rapidly to adenosine extracellularly (Dunwiddie et al.,
1997). Involvement of released intracellular ATP was confirmed
as these effects were either prevented or reversed completely with
both selective and nonselective gap junction hemichannel antag-
onists, including a pannexin-selective concentration of CBX and
the selective peptide blocker 10panx. Furthermore, the I–V curve
during blockade of K channels showed the I–V curve typical of
pannexin hemichannels as reported previously (Romanov et al.,
2007).
Together, these data delineate a direct role for pannexin-1
hemichannel-mediated ATP release in autoregulating CA3 neu-
ronal excitability based on metabolic status. Published reports
have been mixed on the cellular localization of pannexin-1
hemichannels—either showing an exclusively neuronal localiza-
tion of pannexin-1 in hippocampus (Litvin et al., 2006) or pro-
viding evidence for their functional expression in cultured
astrocytes (Iglesias et al., 2009). An autocrine neuronal mecha-
Figure 7. I–V relationship of the reduced [glucose]e-induced current. A, The I–V curve gen-
erated with reduced [glucose]e with cesium-based, 2 mM [ATP]i solution in the presence of
tolbutamide (500 M) in rat CA3 pyramidal neurons. The ramp voltage command (60 to
120 mV, 180 mV/s) was applied before, during reduced [glucose]e and after antagonist
application. The Erev was35.40 1.76 mV (n 8), and this I–V curve was suppressed
significantly by CBX (100M, n 4) or 10panx (100M, n 4). Ramp responses in baseline
and after CBX are largely overlapping; **p 0.01. B, In rat astrocytes recorded in the stratum
radiatum, reduced [glucose]e causes no current with cesium-based, 2mM [ATP]i solution in the
presence of tolbutamide (500M). The ramp voltage commandwas as inA. Ramp responses in
baseline and after 3mMglucose are largely overlapping. Right graph shows the summary of the
current at 60mV (n4). Cell identification of the astrocytes is shown in supplemental Figure 4,
available at www.jneurosci.org as supplemental material.
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nism, rather than one involving neighboring glia, is supported for
several reasons: (1) we manipulated ATP only within the re-
corded neuron, (2) in that neuron we found a pannexin-
dependent current, and (3) we measured no change in current in
identified astrocytes in response to the same manipulation (Fig.
7B). Thus, during reduced [glucose]e with sufficient intracellular
ATP and thus adequate cell energy charge, some neuronal ATP is
released directly to inhibit neuronal excitability via A1Rs—a
neuroprotective pathway to prevent increased excitability, ad-
ditional ATP demand, and neuronal dysfunction (Abdelmalik
et al., 2007).
While it may seem counterintuitive for a cell to release ATP
during lowered extracellular glucose, the high [ATP]i-to-
[adenosine]i ratio, the rapid dephosphorylation of ATP by ecto-
enzymes near A1Rs (Dunwiddie et al., 1997; Cunha et al., 1998),
the functional dominance of the inhibitory A1Rs in hippocampus
(Johansson et al., 2001), and equilibrative transporters to influx
adenosine form a comprehensive set of mechanisms to ensure
both the efficiency and efficacy of this autocrine neuronal regu-
lation. Thus, while the released ATP has little effect on overall
ATP levels, the resulting increase in the local concentration of
extracellular concentration of adenosine hyperpolarizes the neu-
ron directly to reduce further energy demand. The comprehensive
autocrine mechanism described here includes ATP released from
neuronal pannexin hemichannels, subsequent activation of A1Rs,
and ultimately decreased CA3 pyramidal neuron excitability via
opening of postsynaptic KATP channels (Fig. 8).
Unexpectedly, we revealed that postsynaptic A1Rs in hip-
pocampal CA3 pyramidal neurons can couple to KATP channels.
A1R-mediated hyperpolarization in hippocampus has been
shown previously to be coupled to postsynaptic GIRK channels
(Trussell and Jackson, 1987), and we verified ongoing GIRK ac-
tivity in CA3 pyramidal neurons during baseline recording con-
ditions. We confirmed K channels as the source of the outward
current in the autocrine-mediated decrease in excitability, and
determined pharmacologically that the outward current mobi-
lized by reduced [glucose]e is due to the opening of postsynaptic
KATP channels, a new finding in hippocampal neurons.
Previously, a different in vitromodel of
the ketogenic diet (i.e., direct application
of ketones to substantia nigra pars reticu-
lata neurons) demonstrated hyperpo-
larization via KATP channels (Ma et al.,
2007), consistent with our present find-
ings. In this study the KATP channels are
assumed to be opened by the traditional
signal of a decrease in [ATP]i, perhaps in a
localized area inside the cell; direct mea-
surements of ATP and cell energy mole-
cules during maintenance on a ketogenic
diet reveal a net increase. As an alternate
explanation, the KATP channels could also
be coupled to A1Rs (Andoh et al., 2006).
Here we focus on key aspects of a ketone-
based metabolic state—increased ATP
and decreased glucose—and record from
a brain region and cell type relevant to
both experimental seizure models and
clinical seizure disorders.
Current trace fluctuations in reduced
glucose are minimized in the presence of
antagonists or genetic deletion of A1Rs,
suggesting a dynamic feedback. These
fluctuations may be a hysteresis due to transient microdomains
of ATPi and intermittent mobilization of the autocrine response,
which would be expected to have ongoing feedback and associ-
ated fluctuations; future studies could quantify these effects. To-
gether, the novel autocrine mechanism we delineate here
includes ATP released directly from gap junction hemichannels
locatedonCA3pyramidal neurons, subsequent activationof neuro-
nal A1Rs, and ultimately decreased neuronal excitability via opening
of KATP channels (Fig. 8).
As noted, a causal relationship between metabolism and neu-
ronal activity has been well documented in persons with epilepsy
(Hallbo¨o¨k et al., 2007; Remahl et al., 2008; Yum et al., 2008;
Freeman et al., 2009). Either fasting or adhering to a high-fat, low
carbohydrate (ketogenic) diet can offer a highly effective anticon-
vulsant treatment, particularly in children and even in cases of
medically refractory epilepsy (Neal et al., 2008; Zupec-Kania and
Spellman, 2008; Kossof and Rho, 2009). Levels of the ketone
bodies themselves are not well correlated with the therapeutic
effects of the diet (Seymour et al., 1999;Musa-Veloso et al., 2006),
but low glucose is thought to be a key factor (Huttenlocher, 1976;
Freeman et al., 2009). This study combines two consequences of
ketogenic metabolism increasingly considered essential to its
therapeutic effects—increased intracellular ATP and low extra-
cellular glucose (Kim and Rho, 2008). We provide cellular evi-
dence, in a relevant brain region, for a powerful link between
altered metabolism and an increased inhibitory influence of
adenosine, and a new insight into the cooperative role between
ATP and adenosine in regulating neuronal activity.
Augmenting activity of A1Rs offers a long-recognized and
powerful anticonvulsant and neuroprotective influence and has
broad acute and chronic therapeutic potential. The novel auto-
crine neuronal regulation revealed herein may shed light on cel-
lular mechanisms essential for the paradoxical neuroprotective
effects of fasting (Davis et al., 2008) and metabolic (Korde et al.,
2005; Pandya et al., 2007) or glycolytic (Garriga-Canut et al.,
2006; Stafstrom et al., 2009) inhibition, including improved re-
covery after spinal cord injury (Plunet et al., 2008), and could
provide the critical and coveted neuronal mechanism underlying
Figure 8. Schematic of the purinergic autocrine regulation in CA3 pyramidal neurons. With sufficient [ATP]i (1), reducing
[glucose]e (2) inducesneuronalATP releasedirectly viapannexinhemichannels (3); releasedATP is dephosphorylated toadenosine
(4) to activate adenosine A1 receptors (5) and, ultimately, decrease neuronal excitability by opening KATP channels (6).
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the anticonvulsant effects of fasting, ketogenic diet therapy, and
glycolytic inhibition.
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